MCRT Phoenix 2017: The Basics of Myeloma Genetics by Rafael Fonseca, MD

MCRT Phoenix 2017: The Basics of Myeloma Genetics by Rafael Fonseca, MD

MCRT Phoenix 2017: Determining the Right Therapy Strategy by Rafael Fonseca, MDПодробнее

MCRT Phoenix 2017: Determining the Right Therapy Strategy by Rafael Fonseca, MD

MCRT Phoenix 2017: Myeloma Expert Panel (Afternoon)Подробнее

MCRT Phoenix 2017: Myeloma Expert Panel (Afternoon)

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient StoryПодробнее

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient Story

Dr. Rafael Fonseca: A discussion about the utility of gene expression in Multiple MyelomaПодробнее

Dr. Rafael Fonseca: A discussion about the utility of gene expression in Multiple Myeloma

Rafael Fonseca, MD, discusses frontline multiple myeloma treatment patternsПодробнее

Rafael Fonseca, MD, discusses frontline multiple myeloma treatment patterns

Dr. Rafael Fonseca | ASH 2017 | Understanding & harnessing normal plasma cell biologyПодробнее

Dr. Rafael Fonseca | ASH 2017 | Understanding & harnessing normal plasma cell biology

MRD Tests and Applications — Rafael Fonseca, MD | MCRT Webcast August 29 (2/4)Подробнее

MRD Tests and Applications — Rafael Fonseca, MD | MCRT Webcast August 29 (2/4)

MCRT Phoenix 2017: Myeloma Expert Panel (Morning)Подробнее

MCRT Phoenix 2017: Myeloma Expert Panel (Morning)

MCRT Scottsdale 2018: Multiple Myeloma Genetics and MRDПодробнее

MCRT Scottsdale 2018: Multiple Myeloma Genetics and MRD

Pathological optimism: seeking a cure for multiple myeloma | Rafael Fonseca, M.D. | Mayo ClinicПодробнее

Pathological optimism: seeking a cure for multiple myeloma | Rafael Fonseca, M.D. | Mayo Clinic

Rafael Fonseca discusses MOA and Its Impact on Myeloma TreatmentПодробнее

Rafael Fonseca discusses MOA and Its Impact on Myeloma Treatment

Uses of MRD in patients with multiple myelomaПодробнее

Uses of MRD in patients with multiple myeloma

Rafael Fonseca, MD, on the effectiveness of anti-BCMA CAR-T cell therapy in multiple myelomaПодробнее

Rafael Fonseca, MD, on the effectiveness of anti-BCMA CAR-T cell therapy in multiple myeloma

MRD in multiple myeloma: determining responseПодробнее

MRD in multiple myeloma: determining response

MCRT St. Louis 2018: Multiple Myeloma Genetics by Brian Van Ness, PhDПодробнее

MCRT St. Louis 2018: Multiple Myeloma Genetics by Brian Van Ness, PhD

Every Patient Counts, Every Story Matters: Dr. Rafael Fonseca and Jenny AhlstromПодробнее

Every Patient Counts, Every Story Matters: Dr. Rafael Fonseca and Jenny Ahlstrom

What causes multiple myeloma? Rafael Fonseca, M.D., Mayo ClinicПодробнее

What causes multiple myeloma? Rafael Fonseca, M.D., Mayo Clinic

Dr. Fonseca on FISH Testing in Patients With MyelomaПодробнее

Dr. Fonseca on FISH Testing in Patients With Myeloma